Coast Guard gets naloxone mandate; Congress demands overdose data
H.R. 2351 — To direct the Commandant of the Coast Guard to update the policy of the Coast Guard regarding the use of medication to treat drug overdose, and for other purposes. · Filed by Addison McDowell (R-NC) · 2 cosponsors · Introduced Mar 26, 2025 · Passed chamber
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Coast Guard to update its policy on naloxone (Narcan) and similar overdose-reversal medications, requiring these drugs be available at all Coast Guard installations and in operational environments. It also mandates the Coast Guard join a Defense Department tracking system for overdose incidents and report to Congress within two years on naloxone use, fentanyl prevalence, and substance-abuse mitigation efforts among Coast Guard personnel.
Why we flagged it
The bill's operative mechanism is a mandate to expand naloxone availability and reporting within the Coast Guard, framed as a public-health and personnel-safety measure. The opening amendments to maritime drug-trafficking statutes are technical clarifications, not the bill's primary purpose.
What the text implies
- Mandatory participation in a DoD tracking system may create a permanent database of Coast Guard personnel overdose incidents, potentially affecting career advancement, security clearances, or medical discharge decisions if not carefully protected by privacy safeguards.
- The bill requires naloxone availability 'in each operational environment,' which may impose logistical and cost burdens on remote or maritime operations where supply chains are constrained.
The full analysis lists 3 implications of this text.
Who stands to gain
pharmaceutical manufacturers of naloxone and opioid-reversal medications (Amphastar, Adapt Pharma/Pu